Your browser doesn't support javascript.
loading
Plus Sutures for preventing surgical site infection: a systematic review of clinical outcomes with economic and environmental models.
Edwards, M; Graziadio, S; Shore, J; Schmitz, N D; Galvain, T; Danker, W A; Kocaman, M; Pournaras, D J; Bowley, D M; Hardy, K J.
Afiliación
  • Edwards M; York Health Economics Consortium, University of York, Enterprise House, Innovation Way, York, YO10 5NQ, UK. mary.edwards@york.ac.uk.
  • Graziadio S; York Health Economics Consortium, University of York, Enterprise House, Innovation Way, York, YO10 5NQ, UK.
  • Shore J; York Health Economics Consortium, University of York, Enterprise House, Innovation Way, York, YO10 5NQ, UK.
  • Schmitz ND; Johnson & Johnson MEDICAL GmbH, Robert-Koch-Strasse 1, 22851, Norderstedt, Germany.
  • Galvain T; Global Health Economics, Johnson & Johnson Medical Devices, New Brunswick, NJ, USA.
  • Danker WA; Ethicon Inc., 1000 US-202, Raritan, NJ, 08869, USA.
  • Kocaman M; Johnson & Johnson Medical Limited, Berkshire, UK.
  • Pournaras DJ; Department of Bariatric and Metabolic Surgery, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
  • Bowley DM; University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham, B15 2WB, UK.
  • Hardy KJ; Derbyshire Pathology, University Hospitals Derby and Burton NHS Trust, Royal Derby Hospital, Derby, UK.
BMC Surg ; 23(1): 300, 2023 Oct 03.
Article en En | MEDLINE | ID: mdl-37789307
ABSTRACT

BACKGROUND:

Surgical site infections (SSIs) represent ~ 20% of all hospital-acquired infections in surgical patients and are associated with prolonged hospital stay, admission to intensive care, and mortality. We conducted a systematic review with economic and environmental models to assess whether triclosan-coated sutures (Plus Sutures) provide benefits over non-coated sutures in the reduction of SSI risk.

METHODS:

Searches were conducted in fifteen databases. A total of 1,991 records were retrieved. Following deduplication and screening by two independent reviewers, 31 randomized controlled trials in adults and children were included in the review. Similarity of the studies was assessed by narrative review and confirmed by quantitative assessment. A fixed effects meta-analysis of SSI incidence model including all groups of patients estimated a risk ratio of 0.71 (95% confidence interval 0.64 to 0.79) indicating those in the Plus Sutures group had a 29% reduction in the risk of developing an SSI compared with those in the control group (p < 0.001). Safety outcomes were analysed qualitatively.

RESULTS:

The economic model estimated the use of Plus Sutures to result in average cost savings of £13.63 per patient. Plus Sutures remained cost-saving in all subgroup analyses with cost-savings ranging between £11 (clean wounds) and £140 (non-clean wounds). The environmental impact of SSI is substantial, and the model suggests that the introduction of Plus Sutures could result in potential environmental benefits.

CONCLUSIONS:

The evidence suggests that Plus Sutures are associated with a reduced incidence of SSI across all surgery types alongside cost savings when compared with standard sutures.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Triclosán / Antiinfecciosos Locales Tipo de estudio: Clinical_trials / Health_economic_evaluation / Systematic_reviews Límite: Adult / Child / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Triclosán / Antiinfecciosos Locales Tipo de estudio: Clinical_trials / Health_economic_evaluation / Systematic_reviews Límite: Adult / Child / Humans Idioma: En Año: 2023 Tipo del documento: Article